Add like
Add dislike
Add to saved papers

Receptiveness to Patient-Delivered Partner Therapy (PDPT) for Chlamydia Infection: Exploratory Findings From a Sample of Canadian Youth.

OBJECTIVES: To determine hypothetical receptiveness among Canadian 15-24 year old youth to providing and receiving patient-delivered partner therapy (PDPT) for Chlamydia trachomatis infection and to explore patient characteristics associated with receptiveness.

METHODS: An anonymous cross-sectional survey was administered to a convenience sample of 312 youth ages 15-24 years presenting to a youth-focused community health centre (CHC) in Ajax, ON. The survey probed comfort with PDPT for chlamydia, both if the respondent was the hypothetical index case or the hypothetical partner. Participants ranked their hypothetical receptiveness on a five-point Likert Scale. Simple descriptive statistics were performed.

RESULTS: Mean age of respondents was 19.2 years. The majority (87.6%) endorsed previous sexual activity, of which 18.8% reported a previous chlamydia diagnosis. Seventy-eight percent of respondents endorsed hypothetical comfort with providing PDPT, while 65.4% and 53.3% of respondents expressed hypothetical willingness to receive PDPT if they were symptomatic and asymptomatic from chlamydia, respectively. Having multiple recent sexual partners was associated with increased hypothetical receptiveness to PDPT. Age was not correlated with a significant difference in responses.

CONCLUSION: Among 312 Canadian youth, a majority expressed hypothetical comfort with providing and receiving PDPT for C. trachomatis. Having multiple recent sexual partners significantly increased reported potential receptiveness. Within this sample, PDPT thus has a significant potential to reach youth engaging in higher-risk sexual behavior. Variations in comfort based on symptom status emphasized the importance of tailoring partner management strategies to individual patients and of ongoing patient education.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app